Preliminary study on the effect of intestinal flora changes on glucose metabolism in CG-IUGR rats

doi:10.11958/20230026

Abstract

Abstract:

Objective To analyze the relationship between intestinal flora and glucose metabolism changes in CG-IUGR rats by interventing CG-IUGR rats with the intestinal flora of normal rats. Methods SD rats were divided into three groups: the control group, the CG-IUGR group and the CG-IUGR+intestinal bacteria group (n=8 in each group). The CG-IUGR rat model was established by low-calorie diet. The intestinal flora of rats in the control group were transplanted into CG-IUGR rats in the CG-IUGR+intestinal bacteria group at 3-week-old (once a week, 6 times in total). From birth to 8 weeks, the body weight and body length were measured in three groups of rats, and body mass index (BMI) was calculated. The relevant indexes of glucose metabolism were detected in three groups, including fasting blood glucose (FBG), serum fasting insulin (FINS) and serum insulin (INS) at 15 min after glucose loading and tolerance test of glucose and insulin. The mRNA and protein expression levels of skeletal muscle glycogen synthase (GYS)1 and liver GYS2 were detected by real-time fluorescence quantitative polymerase chain reaction (qPCR) and Western blot assay respectively. The activities of GYS in skeletal muscle and liver were detected. 16S rDNA sequencing was used to detect the diversity and composition of intestinal flora in rats of three groups. Results Compared with the control group, the body length, body weight and BMI of rats in the CG-IUGR group were all increased significantly during the process of growth and development. Its serum FINS level decreased, and serum FBG had no significant change. The blood glucose levels of rats in the CG-IUGR group were significantly up-regulated after glucose and INS loading. The serum INS level of rats in the CG-IUGR group was significantly up-regulated at 15 min after glucose loading. The mRNA and protein expression levels of skeletal muscle GYS1 and liver GYS2 in rats of the CG-IUGR group were decreased, and the activity of GYS was also decreased (P<0.05). These above changes of rats in the CG-IUGR+intestinal bacteria group were all improved (P<0.05). Compared with the control group, ACE and Chao1 indices of intestinal bacteria in rats of the CG-IUGR group were lower (P<0.05). Compared with the CG-IUGR group, the relative abundance of intestinal bifidobacterium in rats of the CG-IUGR+intestinal bacteria group was increased (P<0.05). Conclusion IUGR can attenuate the glucose metabolism fuction of CG-IUGR rats by down-regulating the expression and activity of GYS in skeletal muscle and liver tissue. The abnormal glucose metabolism in CG-IUGR rats is related to changes of intestinal flora.

Key words: gastrointestinal microbiome, diabetes mellitus, glycogen synthase, glucose metabolism disorders, fetal growth retardation

CLC Number:

R363

Figures/Tables 12

References 24

[1]	DUAN C, LIU M, XU H, et al. Decreased expression of GLUT4 in male CG-IUGR rats may play a vital role in their increased susceptibility to diabetes mellitus in adulthood[J]. Acta Biochim Biophys Sin(Shanghai), 2016, 48(10):872-882. doi:10.1093/abbs/gmw088.
[2]	高琳琳, 王军, 郭妍妍, 等. 叶酸对IUGR大鼠胎盘VEGF及其受体1表达的影响[J]. 天津医药, 2022, 50(1):73-77.
	GAO L L, WANG J, GUO Y Y, et al. Effects of folic acid on expression of VEGF and receptor 1 in placenta of IUGR rats[J]. Tianjin Med J, 2022, 50(1):73-77. doi:10.11958/20211385.
[3]	袁冰舒, 赵海龙, 李丽娟. 肠道细菌与肥胖及2型糖尿病关系的研究进展[J]. 天津医药, 2019, 47(10):1102-1107.
	YUAN B S, ZHAO H L, LI L J. Research progress on relationship between intestinal flora and obesity and type 2 diabetes[J]. Tianjin Med J, 2019, 47(10):1102-1107. doi:10.11958/20191036.
[4]	GRECH A, COLLINS C E, HOLMES A, et al. Maternal exposures and the infant gut microbiome: a systematic review with meta-analysis[J]. Gut Microbes, 2021, 13(1):1-30. doi: 10.1080/19490976.2021.1897210.
[5]	NULI R, AZHATI J, CAI J, et al. Metagenomics and faecal metabolomics integrative analysis towards the impaired glucose regulation and type 2 diabetes in uyghur-related omics[J]. J Diabetes Res, 2019, 2019:2893041. doi:10.1155/2019/2893041.
[6]	CAO Y, YAO G, SHENG Y, et al. JinQi Jiangtang tablet regulates gut microbiota and improve insulin sensitivity in type 2 diabetes mice[J]. J Diabetes Res, 2019, 2019:1872134. doi:10.1155/2019/1872134.
[7]	LONG W, ZHOU T, XUAN X, et al. IUGR with catch-up growth programs impaired insulin sensitivity through LRP6/IRS-1 in male rats[J]. Endocr Connect, 2022, 11(1):e210203. doi:10.1530/EC-21-0203.
[8]	郑锐丹, 汪无尽, 应艳琴, 等. 生长追赶宫内发育迟缓大鼠早期糖脂代谢及脂肪细胞功能的改变[J]. 中国当代儿科杂志, 2012, 14(7):543-547.
	ZHENG R D, WANG W J, YING Y Q, et al. Effects of intrauterine growth retardation with catch-up growth on sugar-lipid metabolism and adipocyte function in young rats[J]. Chinese Journal of Contemporary Pediatrics, 2012, 14(7):543-547.
[9]	WU Y, YIN G, WANG P, et al. Effects of different diet-induced postnatal catch-up growth on glycolipid metabolism in intrauterine growth retardation male rats[J]. Exp Ther Med, 2020, 20(6):134. doi:10.3892/etm.2020.9263.
[10]	WANG B, CHENG J, WAN H, et al. Early-life exposure to the Chinese famine,genetic susceptibility and the risk of type 2 diabetes in adulthood[J]. Diabetologia, 2021, 64(8):1766-1774. doi:10.1007/s00125-021-05455-x.
[11]	CHEN D, WANG Y Y, LI S P, et al. Maternal propionate supplementation ameliorates glucose and lipid metabolic disturbance in hypoxia-induced fetal growth restriction[J]. Food Funct, 2022, 13(20):10724-10736. doi:10.1039/d2fo01481e.
[12]	REN C, ZHANG Y, CUI W, et al. A polysaccharide extract of mulberry leaf ameliorates hepatic glucose metabolism and insulin signaling in rats with type 2 diabetes induced by high fat-diet and streptozotocin[J]. Int J Biol Macromol, 2015, 72:951-959. doi:10.1016/j.ijbiomac.2014.09.060.
[13]	OYENIHI A B, LANGA S, MUKARATIRWA S, et al. Effects of centella asiatica on skeletal muscle structure and key enzymes of glucose and glycogen metabolism in type 2 diabetic rats[J]. Biomed Pharmacother, 2019, 112:108715. doi:10.1016/j.biopha.2019.108715.
[14]	LUO D, MU T, SUN H. Sweet potato(Ipomoea batatas L.)leaf polyphenols ameliorate hyperglycemia in type 2 diabetes mellitus mice[J]. Food Funct, 2021, 12(9):4117-4131. doi:10.1039/d0fo02733b.
[15]	XIROUCHAKI C E, MANGIAFICO S P, BATE K, et al. Impaired glucose metabolism and exercise capacity with muscle-specific glycogen synthase 1 (gys1) deletion in adult mice[J]. Mol Metab, 2016, 5(3):221-232. doi:10.1016/j.molmet.2016.01.004.
[16]	DENG N, ZHENG B, LI T, et al. Assessment of the phenolic profiles,hypoglycemic activity,and molecular mechanism of different highland barley(Hordeum vulgare L.)varieties[J]. Int J Mol Sci, 2020, 21(4):1175. doi:10.3390/ijms21041175.
[17]	FASSATOUI M, LOPEZ-SILES M, DÍAZ-RIZZOLO D A, et al. Gut microbiota imbalances in Tunisian participants with type 1 and type 2 diabetes mellitus[J]. Biosci Rep, 2019, 39(6):BSR20182348. doi:10.1042/BSR20182348.
[18]	ZHANG L, QIN Q, LIU M, et al. Akkermansia muciniphila can reduce the damage of gluco/lipotoxicity,oxidative stress and inflammation,and normalize intestine microbiota in streptozotocin-induced diabetic rats[J]. Pathog Dis, 2018, 76(4): fty028. doi:10.1093/femspd/fty028.
[19]	XIE X, LIAO J, AI Y, et al. Pi-Dan-Jian-Qing Decoction ameliorates type 2 diabetes mellitus through regulating the gut microbiota and serum metabolism[J]. Front Cell Infect Microbiol, 2021, 11:748872. doi:10.3389/fcimb.2021.748872.
[20]	YU F, HAN W, ZHAN G, et al. Abnormal gut microbiota composition contributes to the development of type 2 diabetes mellitus in db/db mice[J]. Aging (Albany NY), 2019, 11(22):10454-10467. doi:10.18632/aging.102469.
[21]	ZHANG P P, LI L L, HAN X, et al. Fecal microbiota transplantation improves metabolism and gut microbiome composition in db/db mice[J]. Acta Pharmacol Sin, 2020, 41(5):678-685. doi:10.1038/s41401-019-0330-9.
[22]	WANG Y, YANG Z, TANG H, et al. Faecal microbiota transplantation is better than probiotics for tissue regeneration of type 2 diabetes mellitus injuries in mice[J]. Arch Physiol Biochem, 2022:1-9. doi:10.1080/13813455.2022.2080229.
[23]	LI Y, DAI C, YUAN Y, et al. The mechanisms of lncRNA Tug1 in islet dysfunction in a mouse model of intrauterine growth retardation[J]. Cell Biochem Funct, 2020, 38(8):1129-1138. doi:10.1002/cbf.3575.
[24]	相萌, 王春阳, 张力, 等. 黄芩苷对宫内生长迟缓胎鼠胰岛素抵抗及PI3K/AKT通路的影响[J]. 中国新药与临床杂志, 2021, 40(10):718-723.
	XIANG M, WANG C Y, ZHANG L, et al. Effects of baicalin on insulin resistance and PI3K/AKT pathway in fetal rats with intrauterine growth retardation[J]. Chinese Journal of New Drugs and Clinical Remedies, 2021, 40(10):718-723. doi:10.14109/jxnki.xyylc.2021.10.10.

基因名称	引物序列（5′→3′）	产物大小/bp
GYS1	上游：CCTTGACTGTATTGGCTGTG	219
GYS1	下游：ATTTCTTTATCGCTGGACG	219
GYS2	上游：TAAAGCCATCCGTCGTTG	101
GYS2	下游：GGGCAGATATTACCAGCAT	101
β-actin	上游：CCTAGACTTCGAGCAAGAGA	140
β-actin	下游：GGAAGGAAGGCTGGAAGA	140

基因名称	引物序列（5′→3′）	产物大小/bp
GYS1	上游：CCTTGACTGTATTGGCTGTG	219
GYS1	下游：ATTTCTTTATCGCTGGACG	219
GYS2	上游：TAAAGCCATCCGTCGTTG	101
GYS2	下游：GGGCAGATATTACCAGCAT	101
β-actin	上游：CCTAGACTTCGAGCAAGAGA	140
β-actin	下游：GGAAGGAAGGCTGGAAGA	140

组别	FBG/（mmol/L）	FINS/（mIU/L）
Control组	5.22±0.52	55.45±5.76
CG-IUGR组	5.62±0.44	45.54±2.81^a
CG-IUGR+肠菌组	5.35±0.29	55.61±4.50^b
F	1.367	9.755^＊＊

组别	FBG/（mmol/L）	FINS/（mIU/L）
Control组	5.22±0.52	55.45±5.76
CG-IUGR组	5.62±0.44	45.54±2.81^a
CG-IUGR+肠菌组	5.35±0.29	55.61±4.50^b
F	1.367	9.755^＊＊

组别	GYS1	GYS2
Control组	1.00±0.00	1.00±0.00
CG-IUGR组	0.70±0.19^a	0.56±0.17^a
CG-IUGR+肠菌组	0.97±0.25^b	0.88±0.20^b
F	4.822^＊	13.126^＊＊